1. Home
  2. Category
  3. Symptoms/Side Effects

Side Effects

Essentials
NCPD Article

B-Cell Malignancies: The Use of Small Molecule Agents for Treatment and Management

Barbara B. Rogers
CJON 2020, 24(2), 199-204 DOI: 10.1188/20.CJON.199-204
Hematologic B-cell malignancies, which have varying behavior patterns, disease processes, and treatment responses, include non-Hodgkin lymphoma, leukemias, and myeloma. Although monoclonal antibodies and other agents have led to dramatic advances in the treatment of B-cell malignancies, the...
0
No votes yet
Read this Article
Case Study

Managing Hot Flashes After Breast Cancer

Janet S. Carpenter
Beth Lambert
ONF 2000, 27(1), 23-25 DOI:
Mrs. C is a 49-year-old married woman who was diagnosed with breast cancer 16 months ago. She underwent a right modified radical mastectomy with immediate reconstruction followed by six cycles of adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil.
0
No votes yet
Read this Article
Article

Transfusion Reactions: A Case Study of an Ocular Adverse Event During Autologous Transplantation

Ijeoma Julie Eche
Myrna Nahas
Elissa Dunn
Ifeoma Mary Eche
Kerry L. O’Brien
CJON 2019, 23(5), 509-513 DOI: 10.1188/19.CJON.509-513
Background: Transfusion of blood products is an integral part of hematopoietic stem cell transplantation. Because of the risk for myelotoxicity during conditioning regimens, adequate transfusion support is needed. Typical signs and symptoms of transfusion reactions include fever, chills, hives, and...
5
Average: 5 (1 vote)
Read this Article
Article

Understanding Anticipatory Nausea

Ruth M. Eckert
ONF 2001, 1553-1558 DOI:
Purpose/Objectives: To address the concept of anticipatory nausea within the theoretical framework of classical conditioning. Data Sources: Published articles, book chapters. Data Synthesis: Although classical conditioning explains much in the development of anticipatory nausea, other factors also...
0
No votes yet
Read this Article
Clinical Challenges

Hand-Foot Syndrome

Karen Pike
ONF 2001, 1519-1520 DOI:
Ms. K is a 41-year-old female with recurrent ovarian carcinoma. She was diagnosed four years ago with stage III endometrioid carcinoma of the left ovary, underwent reductive surgery, and completed six cycles of cisplatin and paclitaxel. She finished her therapy uneventfully and underwent a negative...
0
No votes yet
Read this Article

Questions, Concerns or Requests

We're just a click away for assistance.